{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "be:AKT",
      "entity_text" : "AKT",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P00533",
      "entity_text" : "EGFR",
      "features" : [ {
        "modification_type" : "unknown",
        "feature_type" : "modification"
      } ],
      "entity_type" : "gene_or_gene_product"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Furthermore, the use of shRNA targeting CD44 impaired the expression of EGFR, deactivated the AKT and ERK pathways, reversed EMT and decreased the migration and invasion ability of cells.",
  "reading_complete" : "2020-08-03T16:44:11Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T16:42:46Z",
  "trigger" : "deactivated",
  "evidence" : [ "EGFR, deactivated the AKT" ],
  "pmc_id" : "4494581",
  "score" : 0
}